Topic: citalopram (4 articles)

Description: Citalopram is a selective serotonin reuptake inhibitor (SSRI) prescribed as an anti-depressant. It was approved by the FDA in 1998. (1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl) 01,3-dihydro-5-isobenzofurancarbonitrile)

Learn about the World CNS Therapeutics Market
******************************
Industry Overview II-1 Factors Influencing Demand II-1 The 'Age Factor' II-1 Role of Diagnostic Techniques II-1 Increasing Disease Awareness II-1 Emergent Technologies II-1 Reimbursement Policies II-2 Market Trends and Issues II-2 Booming Therapeutic Opportunities for Neuro-Degenerative Disorders II-2 Spur in CNS Drug Delivery Technologies II-2 Migraine ... (Fri Sep 05 20:50:08 2008 PDT) [also marketwatch12077, marketwire6302]

US Patent Office Rejects Claims on Forest4s Patent for Bystolict
*****************
(Argentina) Cocaine vs Prescription Drugs: Decrease in First, Increase in Second // (Fri Sep 05 06:49:56 2008 PDT)

more citalopram items (4 articles)

Links

• http://www.erowid.org/pharms/citalopram/

Concept definition

• citalopram